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Ewing sarcoma (EWS) proto-oncoprotein, an RNA-binding protein, is involved in DNA recombination and repair, gene
expression, RNA processing and transport, as well as cell signalling. Chimeric EWS oncoproteins generated by chromosomal
translocations between EWSR1 and the genes of transcription factors cause malignant tumors. To understand the loss of function
by these translocations, the role of the intact EWS protein has to be investigated. The predominantly nuclear localization of the
EWS protein via a transportin-1-mediated mechanism is dependent on the recently identified C-NLS (also known as PY-NLS).
Among other residues in the C-NLS, Y656 interacts with transportin-1 and is essential for its nuclear localization. Here, we show
that Y656 is phosphorylated, which seems to be a critical factor for transportin-1-mediated nuclear import. If Y656 was mutated
cytosolic aggregates of the EWS protein, colocalized with transportin-1, were observed, similar to those described with mutants
of the closely related FUS/TLS protein that had amino acid substitutions in the PY-NLS causing familial amyothrophic lateral
sclerosis.
1. Introduction
The EWS protein is mainly located in the nucleus, accu-
mulated in Cajal bodies and central regions of nucleoli,
but it is also present in cytoplasm and associated with cell
membrane [1, 2]. We have identified and characterized a
nuclear localization and retention signal at the C-terminus
of the EWS protein (C-NLS) (Figure 1(a)), which assures
nuclear accumulation of the protein [3]. The EWS protein
has been shown to be a ligand of transportin-1, a mediator
in nucleocytoplasmic protein transport, amongmany others,
including related RNA-binding proteins such as FUS/TLS,
hnRNP A1, hnRNP M, and Sam68 [4–6]. The C-NLS of
the EWS protein has been classified as PY-NLS, a consensus
sequence recognized by transportin-1 [5]. R648, R652, P655
and Y656 have been found to be essential residues in the C-
NLS for the nuclear transport of the EWS protein [3].
Brk (breast tumour kinases) phosphorylate tyrosine
residues present in the NLS of Sam68 [7], which is highly
homologous to that of the EWS protein (Figure 1(a)). Y440
of Sam68 corresponds to Y656 of the EWS protein. The
residues P and R at position -1 and -4 (from Y) correspond
completely, and both proteins have positive charges at
position -2 (H/R) and -8 (K/R) as well as a negative
charge at -3 (E/D). Phosphorylation and dephosphorylation
regulate subcellular localization of numerous proteins [7].
In the present study, we investigated and found that Y656
in the EWS protein occurs in a phosphorylated state and if
phosphorylation is abolished, it accumulates in the cytosol
colocalized with transportin-1.
2. Results and Discussion
Expression of the EWS-YFP fusion protein resulted exclu-
sively in nuclear accumulation, with high concentration in
nucleoplasmic speckles and a fraction in the subnuclear
central region (Figure 1(b)), thereby interacting with par-
ticular proteins such as the RNA helicases p72 and 68 [8].
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Figure 1: (a) Sequence alignment of PY-NLSs. The homologous regions of C-NLS of the EWS protein, NLS of Sam68 and FUS/TLS protein
and M9 NLS of hnRNP A1 and hnRNP M, classified as PY-NLS are in yellow boxes. Phosphorylated Y656 of the EWS protein and Y440 of
Sam68 are indicated (in red). Positions of identical residues in SAM68 and EWS C-NLS are indicated in bold and residues with identical
charges are underlined. Known positions of the FUS/TLS mutations in ALS are in bold. (b) Subcellular localization of YFP, the C-terminally
tagged EWS-YFP, EWS(Y656A)-YFP, EWS(Y656F)-YFP, and EWS(Y656D)-YFP (in green). Nuclei are shown by DAPI staining (in blue).
Bars, 15 μm.
YFP alone is diffusively distributed between the nucleic and
cytoplasmic compartment. Single amino acid substitutions
of the C-terminal Y656 by alanine, phenylalanine, and
aspartic acid revealed a drastic redistribution of the EWS
protein with cytoplasmic accumulations in the perinuclear
region (Figure 1(b)). The resulting cytoplasmic aggregation
pattern demonstrates that none of these amino acids could
successfully substitute the tyrosine residue. Phenylalanine
substitution does not fulfill the function of the Y656,
implying the importance of the hydroxyl group of tyrosine.
Thus, a possible phosphorylation of this amino acid residue
in nuclear import function seems likely. However, not even
an aspartic acid, which, due to its negative charge, is often
used as phosphomimetic of phosphorylated residues, could
restore the nuclear localization of the protein.
To demonstrate a possible phosphorylation of Y656,
GFP-Zf protein was constructed by fusion of His-GFP with
a part of EWS protein (aa 525–656). This part of the
C-terminal RNA-binding domain of the EWS protein con-
sists of the Zinc finger (Zf) motif followed by the arginine-
glycine rich box 3 (RGG3) and C-NLS (Figure 2(a)). This
fragment of the EWS protein (aa 525–656), hereafter called
Zf, contains Y656 as the only tyrosine residue and at the same
time is large enough to avoid diffusive nuclear import of
the GFP-Zf fusion protein. Additionally, the construct GFP-
Zf(Y656A), having alanine as the single amino acid substi-
tution for Y656, was produced as a negative control. GFP-Zf
shows the subcellular localization pattern of the full-length
EWS protein. However, its subnuclear partition is different
from that of the full-length protein, as previously described
[3] (Figure 2(b)). GFP-Zf(Y656A) reveals the characteristic
cytoplasmic distribution as is typical for Y656 mutations
of the full-length EWS protein (Figure 2(b)). To show that
the cytoplasmic accumulations of the GFP-Zf(Y656A) are
not aggregation and precipitation of an insoluble mutant
protein, but the result of specific inactivation of NLS
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Figure 2: (a) Schematic representation of the N-terminally tagged
GFP-Zf fusion protein. 6His-GFP is fused to the EWS mutant
protein (aa 525–656). (b) Representative examples of the subcellular
localization (all cells expressing the construct are showing the
indicated localization) of GFP-Zf, GFP-Zf(Y656A), and GFP-
Zf(Y656A)-SV40NLS (in green). Nuclei are shown byDAPI staining
(in blue). Bars, 15 μm. (c) Phosphorylation analysis of GFP-Zf and
GFP-Zf(Y656A) using antiphosphotyrosine antibodies. GFP-Zf and
GFP-Zf(Y656A) fusion protein bands are detectable at ∼40 kDa.
The additional phosphorylated protein band detected at ∼55 kDa
was identified as p54nrb.
function, GFP-Zf(Y656A) was fused with the canonical SV40
NLS. GFP-Zf(Y656A)-SV40NLS shows complete nuclear
localization similar to the GFP-Zf without any detectable
cytoplasmic aggregates (Figure 2(b)).
Transportin GFP-Zf(Y656A)DAPI Merged
Figure 3: Colocalization of transportin-1 (in magenta) and GFP-
Zf(Y656A) (in green). Nuclei are shown by DAPI staining (in blue).
Bars, 15 μm. Representative examples of the subcellular localization
are shown (all cells expressing the constructs are showing the
indicated localization).
GFP-Zf and GFP-Zf(Y656A) fusion proteins containing
6His-tag at the N-terminus of GFP were expressed in eukary-
otic HEK 293(T) cells, extracted, subjected to SDS-PAGE,
and analyzed on Western blots by using antiphosphotyrosine
antibody. Phosphorylation was detected in GFP-Zf (band
at ∼40 kDa) but not in GFP-Zf(Y656A) and not in the
untransfected sample (Figure 2(c)). The Western blots with
the same samples but with anti-C-terminal EWS antibody,
that recognized both fusion proteins, demonstrate similar
expression level of both proteins (Figure 2(c)). The multiple
protein bands detected by anti-C-terminal EWS antibody
in the lysate of untransfected HEK 293(T) cells reflect
different degradation fragments of endogenous EWS protein
(unpublished observations). Phosphorylation of a protein at
55 kDa was also detected. This protein was identified by mass
spectrometry as the nuclear RNA- and DNA-binding protein
p54nrb. Whatever reasons might be responsible for binding
to the resin (possibly endogenous histidine residues located
in close proximity), p54nrb can serve here as an internal
standard for equal loading.
As nuclear import of the EWS protein is mediated
by transportin-1 [5], we have visualized the subcellu-
lar localization of transportin-1. In cells expressing GFP-
Zf(Y656A), transportin-1 colocalizes with the mutant GFP-
Zf(Y656A) in cytoplasmic accumulations, apart from its
characteristic homogeneous nucleocytoplasmic distribution
(Figure 3). Conceivably, the part of transportin-1 bound to
GFP-Zf(Y656A) is spatially restricted to these cytoplasmic
structures and cannot fulfill its functions in nucleocytoplas-
mic transport due to the missing phosphorylated tyrosine.
This finding indicates that phosphorylation is not required
for transportin-1 binding which is in accordance with
previous data showing that unphosphorylated PY-NLS of
EWS or the mutated peptides containing Y656A still bind
recombinant transportin-1 [5]. Why are these mutations
then causing loss of nuclear import function? Possibly,
binding in the absence of a phosphorylated C-NLS cannot
induce a conformational change in transportin-1, which
might be essential for recruiting or binding to other partners
in the nuclear import process and leads, thus, to cytoplasmic
accumulations of the transportin-1-EWS complex.
Recently, mutations in FUS/TLS have been shown to be
responsible for familial amyotrophic lateral sclerosis (ALS),
and mutants of the FUS/TLS protein accumulate in the
cytoplasm of cortical neurons and lower motor neurons in
the brain of ALS patients [9, 10]. These results indicate that
4 Sarcoma
mutant FUS/TLS has a tendency to be insoluble compared to
the wild type. Remarkably, mutations are found in the C-NLS
(PY-NLS) of FUS/TLS (Figure 1(a)), and the cytoplasmic
accumulation is similar with that of the EWS mutant GFP-
Zf(Y656A). Our present data indicate that these cytoplasmic
aggregations (or, alternatively, accumulations of protein
complexes) of FUS/TLS are formed, as in case of the EWS
mutants, due to a disturbed nuclear import leading to an
increased cytoplasmic concentrations of these proteins. In
the normal steady state, the predominant amount of these
proteins is transported into the nucleus. Knowledge about
the mechanisms of nuclear import, including the role of
tyrosine phosphorylation for the function of C-NLS, might
have an impact particularly in better understanding the
pathogenesis of ALS in order to be able to develop a strategy
for its treatment. In addition, it is of interest to confirm the
presence of transportin-1 in these cytoplasmic aggregations
and to further test the functionality and the role of this
restricted protein in progression of the disease.
It is possible that different kinases are able to phospho-
rylate the EWS protein individually in a cell cycle-dependent
and a cell compartment-dependent manner, as it has been
found with Sam68 containing PY-NLS. Sam68 is phospho-
rylated in the nucleus by Brk (breast tumour kinases) and at
the cell membrane by Src kinases [7]. Remarkably, kinases
of the Src-subfamily are localized in the cytoplasm and can
be bound, due to N-terminal myristoylation, to the inner
face of the plasma membrane [11], where the EWS protein
has also been found [2, 12]. The members of the Brk family,
related to the Src family, lack a myristoylation site, and
cytoplasmic and nuclear localization is more typical for these
kinases [13, 14]. Tyrosine kinases, known to interact with
the EWS protein, are Pyk2 and Bruton tyrosine kinase, as
well as Lck, a member of Src kinases [15, 16]. Src kinases
and Pyk2 recognize a similar tyrosine phosphorylationmotif,
which suggests that the latter might phosphorylate Y656
of the EWS protein. Conceivably, tyrosine phosphorylation
might regulate, apart from its role in nucleocytoplasmic
transport, interactions with other proteins or with RNA, as
was observed with the related Sam68 and QKI [7, 13, 17].
Although phosphorylation of Y656 in the EWS protein
seems to be essential, it might not be the exclusive reg-
ulating factor for nuclear localization, since other known
or predicted mechanisms can be recruited to cooperatively
or sequentially control nucleocytoplasmic distribution of a
particular protein. SUMO-ylation, another reversible post-
translational modification of Sam68 [18] and of hnRNP M,
has been described to play a role in nucleocytoplasmic shut-
tling of mRNA-binding protein complexes [19]. Remarkably,
the SUMO-ylation motif GKMD is predicted with high
probability also in the C-NLS region of the EWS protein
(http://us.expasy.org/, SUMOplot) and is a potential subject
for further investigation.
3. Materials and Methods
3.1. Expression Constructs. The eukaryotic vectors for expres-
sion of the EWS-YFP, EWS(Y656A)-YFP, and EWS(Y656F)-
YFP fusions were constructed as described [3]. To produce
the EWS(Y656D)-YFP mutant, the Y656D reverse primer
was used. The vectors for expression of His-GFP-Zf and
His-GFP-Zf(Y656A) fusions were constructed as follows.
For construction of pcDNA3.1(−)B-Zf and pcDNA3.1(−)B-
Zf(Y656A) expression vectors, Zf and Zf(Y656A) fragments
were amplified by traditional PCR using EWSR1 cDNA as
template and Zf-XhoI-NotI-forward and EcoRI-stop-reverse
or Y656A-stop-reverse primers 5′-TCTCTCGAGCGGCCG-
CGCCACCATGAATCCGGGTTGTGGAAACCAGAA-3′
and 5′-CCGAATTCTCAGTAGGGCCGATCTCTGCGC-
TCCTG-3′, or 5′-CCGAATTCTCAGGCGGGCCGATCT-
CTGCGCTCCTG-3′, respectively. The PCR products
were treated with restriction enzymes XhoI and EcoRI
and subcloned into pcDNA3.1(−)B/myc-His (Invitrogen)
to generate in-frame fusions. Finally, the His-GFP-Zf
and His-GFP-Zf(Y656A) vectors were constructed by
amplification of the His-GFP fragment from EWS-Myc-
6xHis/pEGFP-N2, a derivative of pEGFP-N2 plasmid
(Clontech) using the NheI-His-forward and NotI-GFP-
reverse primers 5′-TCTGCTAGCGCCACCATGGCCGTC-
GACCATCATCATCATCATCAT-3′ and 5′-TGCGTC-
GCGGCCGCTCTTGTACAGCTCGTCCATGCCGAG-3′,
respectively, and digestion with the appropriate restriction
enzymes, and by cloning the resulting product into the
pcDNA3.1(−)B-Zf and pcDNA3.1(−)B-Zf (Y656A) plas-
mids. To obtain His-GFP-Zf(Y656A)-SV40NLS, His-GFP-
Zf(Y656A) vector was fused with an NLS from SV40
large T antigen (PKKKRKV). The oligonucleotides 5′-AAT-
TCCCAAAAAAGAAGAGAAAGGTCAGG-3′ and 5′-AGC-
TTCTGACCTTTCTCTTCTTTTTTGGG-3′ were annealed,
and the resulting fragment was digested with restriction
enzymes EcoRI-HindIII and was inserted into His-GFP-
Zf(Y656A).
3.2. Cell Culture and Transfections. Human embryonic kid-
ney (HEK) 293 (T) cells, kindly provided by Professor P.
Sonderegger (Department of Biochemistry, University of
Zurich, Switzerland), were grown in Dulbecco’s Modified
Eagle’s Medium (DMEM) (Sigma) supplemented with 10%
fetal bovine serum (FBS) (Life technologies) and 1% (w/v)
each of penicillin and streptomycin (Life technologies) in
a humidified 10% CO2 atmosphere at 37◦C. For visual-
ization analysis, HEK 293 T cells were cultured on glass
cover slips to 40% confluency and transiently transfected
with mammalian expression constructs using the method
of calcium phosphate precipitation. For protein visualiza-
tion, the cells were fixed 24 h after transfection with 4%
paraformaldehyde (PFA) for 5min and stained with 4′,6-
diamidino-2-phenylindol (DAPI) (Roche). Cover slips were
mounted using Vectashiled medium (Vector) onto glass
slides, and the cells were analyzed by fluorescence and confo-
cal microscopy.
3.3. Antibodies, Protein Purification, and Western Blotting.
Primary rabbit anti-C-terminal EWS antibody SE 680, kindly
provided by Dr. O. Delattre (Institut Curie, Pathologie
Mole´culaire des Cancers, Paris Cedex), was used with
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1 : 5000 dilution. Primary mouse anti-transportin-1 anti-
body (TNPO1, ab10303, Abcam) was kindly provided
by Professor I. Stamenkovic (Department of Experimen-
tal Pathology, Institute of Pathology, CHUV, Lausanne,
Switzerland). Primary rabbit antiphosphotyrosine antibody
(Zymed) was used with 1 : 2000 dilution. The results were
confirmed by using primary mouse antiphosphotyrosine
antibody (P-Tyr-100, Cell Signaling) with 1 : 2000 dilution
(data not shown). The secondary goat antirabbit and goat
antimouse antibodies, respectively, coupled to horseradish
peroxidase (Sigma) were used with 1 : 2000 dilution. His-
GFP-Zf and His-GFP-Zf(Y656A) protein purification by
His-SELECT Nickel affinty gel (Sigma) was performed
as described [2]. In all the purification buffers, sodium
orthovanadate was added as protein phosphatase inhibitor.
Western blotting was performed as described [12] with
some modifications. In case of phosphotyrosine detection,
3% BSA instead of nonfat milk powder was used as blocking
agent and in antibody solutions.
3.4. Confocal Microscopy. Laser-scanning confocal fluores-
cence microscopy was performed using a Leica SP2 AOBS
UV CLSM microscope and HCX PL APO lbd.BL 63.0x
NA 1.40 OIL UV objective. Images were acquired using
excitation wavelengths of 405 nm and 514 nm and the
emission wavelengths of 470 nm and 528 nm for DAPI
and YFP, respectively. Images were captured digitally using
Leica software and processed using Adobe Photoshop 8.0.
The stacks of images were imported into Imaris (Bitplane)
software for the 3D rendering of the images.
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